|
|
10/26/2004 8:53:24 AM ET
SWISS MEDICA EXHIBITS AT SHOPPERS DRUG MART PHARMACY CONFERENCE; MEETS WITH OVER 1000
PHARMACISTS
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB: SWME
October 26, 2004
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB: SWME
October 26, 2004
SWISS MEDICA EXHIBITS AT SHOPPERS DRUG MART PHARMACY CONFERENCE; MEETS WITH OVER 1000
PHARMACISTS
Toronto, Canada – Swiss Medica exhibited at the Shoppers Pharmacy Conference on October 16th at the
Toronto Congress Centre, which was attended by approximately 1,200 pharmacists. The purpose of the
conference was to educate and inform the Shoppers Drug Mart pharmacists about the products they carry in
their stores. Swiss Medica’s Vice President of Sales and Marketing, Michael Bain, and staff met with 90% of the
pharmacists attending the show, providing marketing information and samples of the O24™ Essential Oil Pain
Neutralizer. Mr. Bain held eight informational sessions with larger groups of pharmacists to help explain the
O24™ pain relief product and to respond to the overwhelming consumer response the pharmacists recently
received during the latest media coverage of the product.
Mr. Bain said, “It was exciting to engage such a large number of highly respected pharmacists and to hear them
praise the O24™ Essential Oil Pain Neutralizer. They were eager to learn more about the product that has been
driving a large number of consumers into their stores after our recent media appearances. Many pharmacists
had announced they had resold O24™ multiple times during the past six weeks.”
Other Shoppers Drug Mart Pharmacy Conferences are scheduled later this year in Montreal and Calgary.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be
a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
visit our websites at www.swissmedica.com and www.024zone.com
Swiss Medica’s flagship product, the 024™ Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The
024™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits
by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout
Canada in leading pharmacies and natural food stores. It is available in the United States and elsewhere by
visiting www.024zone.com, for ordering details and store locators.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
transactions being contemplated, risks related to international sales and potential foreign currency exchange
fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s
periodic reports filed with the United States Securities and Exchange Commission and other regulatory
authorities.
Investor Relations Contact:
David Jones
Swiss Medica Inc.
1 866 485 4243
djones@swissmedica.com
|
|
